Barbiturates enhance retinoic acid or 1,25-dihydroxyvitamin D3-induced differentiation of leukemia HL-60 cells
- PMID: 1648909
- DOI: 10.1016/0006-291x(91)91808-p
Barbiturates enhance retinoic acid or 1,25-dihydroxyvitamin D3-induced differentiation of leukemia HL-60 cells
Abstract
In the presence of 1 nM retinoic acid (RA), pentobarbital markedly enhanced differentiation of HL-60 cells to granulocytic cells. In the absence of RA, pentobarbital by itself did not induce cell differentiation. Similarly, pentobarbital enhanced the action of 1,25-dihydroxyvitamin D3 to induce differentiation of HL-60 cells into monocyte/macrophage lineage. The potency of various barbiturates to enhance cell differentiation was closely correlated with their activity to inhibit protein kinase C of HL-60 cells. In contrast to staurosporine, however, barbiturates did not affect the action of differentiation inducers of other types such as dimethyl sulfoxide, dibutyryl cyclic AMP or actinomycin D.
Similar articles
-
Staurosporine, a novel protein kinase inhibitor, enhances HL-60-cell differentiation induced by various compounds.Exp Hematol. 1988 Jan;16(1):42-8. Exp Hematol. 1988. PMID: 2826200
-
Control of macrophage cell differentiation in human promyelocytic HL-60 leukemia cells by 1,25-dihydroxyvitamin D3 and phorbol-12-myristate-13-acetate.Cancer Res. 1983 Oct;43(10):4989-96. Cancer Res. 1983. PMID: 6576856
-
Two stages of the differentiation of HL-60 cells induced by 1 alpha,25 dihydroxyvitamin D3; commitment by 1 alpha,25 dihydroxyvitamin D3 and promotion by DMSO.Biosci Rep. 1986 Jan;6(1):95-101. doi: 10.1007/BF01145184. Biosci Rep. 1986. PMID: 2421801
-
Retinoic acid-induced differentiation of the human promyelocytic leukemia cell line, HL-60, and fresh human leukemia cells in primary culture: a model for differentiation inducing therapy of leukemia.Eur J Haematol. 1987 Apr;38(4):289-302. doi: 10.1111/j.1600-0609.1987.tb00001.x. Eur J Haematol. 1987. PMID: 3038598 Review. No abstract available.
-
Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications.Blood. 1983 Oct;62(4):709-21. Blood. 1983. PMID: 6192859 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources